46544 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 11
00:06 UTC
|
CON
Concentra Group Holdings Parent
|
◎ Target | Benjamin Rossi ★★★★★ #218 | Overweight | $34.00→ $43.00+26.5% |
|
Sep 11
00:06 UTC
|
COCO
Vita Coco
|
◎ Target | Michael Lavery ★★★☆☆ #1755 | Overweight | $89.00→ $83.00-6.7% |
|
Sep 11
00:06 UTC
|
CNM
Core & Main
|
◎ Target | Matthew Bouley ★★★☆☆ #1511 | Overweight | $62.00→ $61.00-1.6% |
|
Sep 11
00:06 UTC
|
CNM
Core & Main
|
◎ Target | Mike Dahl not yet tracked | Outperform | $63.00→ $60.00-4.8% |
|
Sep 11
00:06 UTC
|
CNM
Core & Main
|
◎ Target | Sam Reid ★★☆☆☆ #2768 | Overweight | $65.00→ $48.00-26.2% |
|
Sep 11
00:06 UTC
|
CNM
Core & Main
|
◎ Target | David Manthey ★★★★☆ #747 | Outperform | $66.00→ $57.00-13.6% |
|
Sep 11
00:06 UTC
|
CNM
Core & Main
|
◎ Target | Keith Hughes ★★★☆☆ #1945 | Hold | $50.00→ $45.00-10.0% |
|
Sep 11
00:06 UTC
|
CLDX
Celldex Therapeutics
|
◎ Target | Judah Frommer ★★☆☆☆ #2408 | Overweight | $46.00→ $50.00+8.7% |
|
Sep 11
00:06 UTC
|
CHWY
Chewy
|
◎ Target | Justin Kleber ★★☆☆☆ #2866 | Outperform | $30.00→ $28.00-6.7% |
|
Sep 11
00:06 UTC
|
CHWY
Chewy
|
◎ Target | Scott Devitt ★★★☆☆ #1943 | Neutral | $25.00→ $24.00-4.0% |
|
Sep 11
00:06 UTC
|
CHWY
Chewy
|
◎ Target | William Kerr not yet tracked | Buy | $34.00→ $32.00-5.9% |
|
Sep 11
00:06 UTC
|
CHWY
Chewy
|
◎ Target | Steven Shemesh ★★★☆☆ #2050 | Outperform | $34.00→ $31.00-8.8% |
|
Sep 11
00:06 UTC
|
CHWY
Chewy
|
◎ Target | Lauren Schenk not yet tracked | Overweight | $37.00→ $36.00-2.7% |
|
Sep 11
00:06 UTC
|
CHH
Choice Hotels International
|
◎ Target | Patrick Scholes ★★★☆☆ #1668 | Buy | $128.00→ $129.00+0.8% |
|
Sep 11
00:06 UTC
|
CASY
Casey's General Stores
|
◎ Target | Bradley B. not yet tracked | Overweight | $970.00→ $780.00-19.6% |
|
Sep 11
00:06 UTC
|
CASY
Casey's General Stores
|
◎ Target | Mark Carden ★★★☆☆ #987 | Neutral | $925.00→ $720.00-22.2% |
|
Sep 11
00:06 UTC
|
BMNR
BitMine Immersion Technologies
|
◎ Target | Gareth Gacetta not yet tracked | Overweight | $30.60→ $63.60+107.8% |
|
Sep 11
00:06 UTC
|
BKR
Baker Hughes
|
◎ Target | Charles Minervino ★★★★☆ #931 | Positive | $72.00→ $75.00+4.2% |
|
Sep 11
00:06 UTC
|
BKR
Baker Hughes
|
◎ Target | Josh Silverstein ★★☆☆☆ #2447 | Neutral | $71.00→ $70.00-1.4% |
|
Sep 11
00:06 UTC
|
BIIB
Biogen
|
◎ Target | Morten Herholdt not yet tracked | Reduce | $165.00→ $175.00+6.1% |
|
Sep 11
00:06 UTC
|
BHP
BHP Group
|
◎ Target | firm only | Neutral | GBX 3,250→ GBX 3,350+3.1% |
|
Sep 11
00:06 UTC
|
BG
Bunge Global
|
◎ Target | Manav Gupta ★★★★☆ #580 | Buy | $145.00→ $155.00+6.9% |
|
Sep 11
00:06 UTC
|
BBOT
BridgeBio Oncology Therapeutics
|
◎ Target | Andrew Berens ★★★★★ #175 | Outperform | $27.00 |
|
Sep 11
00:06 UTC
|
AZO
AutoZone
|
◎ Target | Zachary Fadem ★★★☆☆ #1766 | Overweight | $4,150.00→ $3,500.00-15.7% |
|
Sep 11
00:06 UTC
|
AYA
Aya Gold & Silver
|
◎ Target | firm only | Outperformer | C$41.50→ C$48.00+15.7% |
|
Sep 11
00:06 UTC
|
AYA
Aya Gold & Silver
|
◎ Target | firm only | Outperform | C$41.00→ C$46.00+12.2% |
|
Sep 11
00:06 UTC
|
AYA
Aya Gold & Silver
|
◎ Target | firm only | Outperform | C$32.00→ C$45.00+40.6% |
|
Sep 11
00:06 UTC
|
AWK
American Water Works
|
◎ Target | Gregg Orrill ★★☆☆☆ #2854 | Buy | $156.00→ $162.00+3.8% |
|
Sep 11
00:06 UTC
|
AVAV
AeroVironment
|
◎ Target | Gavin Parsons ★★★☆☆ #2042 | Neutral | $166.00→ $170.00+2.4% |
|
Sep 11
00:06 UTC
|
AVAV
AeroVironment
|
◎ Target | Seth Seifman ★★★★☆ #802 | Overweight | $200.00→ $210.00+5.0% |
|
Sep 11
00:06 UTC
|
ATLX
Atlas Lithium
|
◎ Target | Heiko F. Ihle not yet tracked | Buy | $12.50→ $11.50-8.0% |
|
Sep 11
00:06 UTC
|
ASO
Academy Sports and Outdoors
|
◎ Target | Cristina Fernandez ★★☆☆☆ #2465 | Outperform | $60.00→ $63.00+5.0% |
|
Sep 11
00:06 UTC
|
ASO
Academy Sports and Outdoors
|
◎ Target | Adrienne Yih ★★★☆☆ #1643 | Equal Weight | $50.00→ $53.00+6.0% |
|
Sep 11
00:06 UTC
|
ASO
Academy Sports and Outdoors
|
◎ Target | Michael Lasser ★★★★☆ #876 | Neutral | $55.00→ $58.00+5.5% |
|
Sep 11
00:06 UTC
|
ASO
Academy Sports and Outdoors
|
◎ Target | Joseph Civello ★★★☆☆ #1841 | Hold | $52.00→ $54.00+3.8% |
|
Sep 11
00:06 UTC
|
ALK
Alaska Air Group
|
◎ Target | Atul Maheswari ★★☆☆☆ #2771 | Buy | $56.00→ $52.00-7.1% |
|
Sep 11
00:06 UTC
|
AEO
American Eagle Outfitters
|
◎ Target | Alex Straton not yet tracked | Equal Weight | $18.00→ $17.00-5.6% |
|
Sep 11
00:06 UTC
|
AEO
American Eagle Outfitters
|
◎ Target | Jay Sole ★★★☆☆ #2211 | Buy | $31.00→ $27.00-12.9% |
|
Sep 11
00:06 UTC
|
AEO
American Eagle Outfitters
|
◎ Target | Dana Telsey ★★★☆☆ #1582 | Market Perform | $20.00→ $18.00-10.0% |
|
Sep 11
00:06 UTC
|
ABNB
Airbnb
|
◎ Target | Patrick Scholes ★★★☆☆ #1668 | Hold | $134.00→ $161.00+20.1% |
|
Sep 11
00:06 UTC
|
ABBV
AbbVie
|
◎ Target | Rajesh Kumar ★★★☆☆ #1515 | Buy | $300.00→ $315.00+5.0% |
|
Sep 11
00:06 UTC
|
AAL
American Airlines Group
|
◎ Target | Atul Maheswari ★★☆☆☆ #2771 | Buy | $18.00→ $17.00-5.6% |
|
Sep 11
00:06 UTC
|
TLS
Telos
|
↓ Downgrade | Daniel Ives ★★★★☆ #844 | Outperform→ Neutral | $5.00 |
|
Sep 11
00:06 UTC
|
TENB
Tenable
|
↓ Downgrade | Daniel Ives ★★★★☆ #844 | Outperform→ Underperform | |
|
Sep 11
00:06 UTC
|
QLYS
Qualys
|
↓ Downgrade | Daniel Ives ★★★★☆ #844 | Outperform→ Neutral | $175.00 |
|
Sep 11
00:06 UTC
|
DT
Dynatrace
|
↓ Downgrade | firm only | Outperform→ Neutral | $54.00 |
|
Sep 11
00:06 UTC
|
DCCPF
DCC
|
↓ Downgrade | firm only | Buy→ Hold | |
|
Sep 11
00:06 UTC
|
COO
Cooper Companies
|
↓ Downgrade | Jason Bednar ★★★☆☆ #1196 | Overweight→ Neutral | $86.00→ $59.00-31.4% |
|
Sep 11
00:06 UTC
|
CHWY
Chewy
|
↓ Downgrade | Michael Lasser ★★★★☆ #876 | Neutral→ Hold | $28.00 |
|
Sep 11
00:06 UTC
|
CHKP
Check Point Software Technologies
|
↓ Downgrade | Daniel Ives ★★★★☆ #844 | Outperform→ Neutral | $135.00 |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.